Retinal Cell Transplantation Tolerance and Rejection

视网膜细胞移植耐受和排斥

• 批准号: 6789520
• 负责人: JUDITH A KAPP
• 金额: $ 32.63万
• 依托单位: UNIVERSITY OF ALABAMA AT BIRMINGHAM
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-07-01 至 2008-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6789520
• 关键词: T cell receptor; artificial immunosuppression; blindness; cyclosporines; eye transplantation; genetically modified animals; helper T lymphocyte; histocompatibility; histocompatibility antigens; laboratory mouse; lymph nodes; macular degeneration; retina; suppressor T lymphocyte; transplant rejection

DESCRIPTION (provided by applicant): Age-related macular degeneration (AMD) is a major cause of blindness in the United States. Replacement of dead or damaged cells with healthy retinal cells is a very promising approach to the treatment of this, and other, retinal diseases. Our long-term goal is to develop the methods for transplanting retinal pigment epithelial (RPE) cells early in the course of AMD to rescue photoreceptor cells. The central hypothesis of this proposal is that the identification of the immunological mechanisms, which are responsible for RPE transplant rejection, will provide therapeutic targets for inducing long-term graft acceptance. The role of CD4+ and CD8+ T cells in rejection will be tested by adoptively transferring them into immunodeficient, recombinase (Rag-1) knockout mice before transplantation of allogeneic RPE. The relative contribution of major and minor histocompatibility antigens to RPE rejection will be assessed using recombinant, inbred strains of mice. The mechanisms by which RPE grafts are rejected will be determined using T cell receptor (TCR) transgenic mice and RPE expressing defined transplantation antigens. Activation and proliferation of adoptively transferred TCR transgenic T cells will be tracked in lymph nodes and the eyes of transplant recipients. TCR T cells recovered from the eyes will be analyzed for various functional activities. Finally, the hypothesis that allograft-specific tolerance can prolong survival of RPE in the absence of continuous treatment with immunosuppressive agents will be tested. Results from these studies should identify strategies to prevent rejection that can be tested in preclinical models of RPE transplantation.

描述（由申请人提供）：年龄相关性黄斑变性（AMD）是美国失明的主要原因。用健康的视网膜细胞替代死亡或受损的细胞是治疗这种疾病和其他视网膜疾病的一种非常有前途的方法。我们的长期目标是开发在AMD早期移植视网膜色素上皮细胞（RPE）的方法来拯救光感受器细胞。该建议的中心假设是，确定导致RPE移植排斥反应的免疫机制，将为诱导长期移植接受提供治疗靶点。